TOP END CARS ,means what exactly?

Quote
















































Fleet benefit is going to SIGNIFICANTLY down grade now that JNJ is running Actelion. No one will answer any questions about the changes which....... in big Pharma means..... here comes the douching!!

If the absolute shit package they're offering for health care is a clue- we're going to move from one of the best fleet offerings in the industry to the shittiest.

The silver lining? Nearly every rep here is looking for a new job which will open up a lot of positions for people looking to get into rare disease. Come to Actelion, get your one year of rare disease experience & then move on to oncology or another rare disease company that has awesome pay & benefits that are a standard in these spaces.

Horrible time for JNJ to introduce so many distractions & chase off all of their tenured reps with generic competition coming. Anyone who has sold against generics before knows that the best insulation against generic erosion is strong rep relationships. JNJ Actelion will become a revolving door sales force.

Too bad they didn't do any homework to learn why we all have been here for a decade or longer. Not only are we all leaving- we're leaving as whole districts. We'll go kick ass together- for a company that knows what we're worth.
 






anonymous said:
Fleet benefit is going to SIGNIFICANTLY down grade now that JNJ is running Actelion. No one will answer any questions about the changes which....... in big Pharma means..... here comes the douching!!

If the absolute shit package they're offering for health care is a clue- we're going to move from one of the best fleet offerings in the industry to the shittiest.

The silver lining? Nearly every rep here is looking for a new job which will open up a lot of positions for people looking to get into rare disease. Come to Actelion, get your one year of rare disease experience & then move on to oncology or another rare disease company that has awesome pay & benefits that are a standard in these spaces.

Horrible time for JNJ to introduce so many distractions & chase off all of their tenured reps with generic competition coming. Anyone who has sold against generics before knows that the best insulation against generic erosion is strong rep relationships. JNJ Actelion will become a revolving door sales force.

Too bad they didn't do any homework to learn why we all have been here for a decade or longer. Not only are we all leaving- we're leaving as whole districts. We'll go kick ass together- for a company that knows what we're worth.
Click to expand...

Ha good luck with that. Mediocre reps get mediocre opportunities...
 
















































Top Bottom
Back
Quote